Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans-Reference-Cited by-同舟云学术

Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans

Published:2020-01-09 Issue:2 Volume:67 Page:331-343
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Ponce Antonio J.,Galván-Salas Tomás,Lerma-Alvarado Ricardo M.,Ruiz-Herrera Xarubet,Hernández-Cortés Tomás,Valencia-Jiménez Rodrigo,Cárdenas-Rodríguez Laura E.,Martínez de la Escalera Gonzalo,Clapp Carmen,Macotela Yazmín^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-019-02170-x.pdf

Reference61 articles.

1. M. Andersen, D. Glintborg, Metabolic syndrome in hyperprolactinemia. Front Horm. Res. 49, 29–47 (2018). https://doi.org/10.1159/000486000

2. N.A. Pala, B.A. Laway, R.A. Misgar, R.A. Dar, Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline. Diabetol. Metab. Syndr. 7, 99 (2015). https://doi.org/10.1186/s13098-015-0094-4

3. R.S. Auriemma, D. De Alcubierre, R. Pirchio, R. Pivonello, A. Colao, Glucose abnormalities associated to prolactin secreting pituitary adenomas. Front Endocrinol. 10, 327 (2019). https://doi.org/10.3389/fendo.2019.00327

4. R. Landgraf, M.M. Landraf-Leurs, A. Weissmann, R. Horl, K. von Werder, P.C. Scriba, Prolactin: a diabetogenic hormone. Diabetologia 13(2), 99–104 (1977)

5. L.B. Creemers, P.M. Zelissen, J.W. van ‘t Verlaat, H.P. Koppeschaar, Prolactinoma and body weight: a retrospective study. Acta Endocrinol. 125(4), 392–396 (1991)

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of systemic, metabolic, and molecular changes following prospective change to low-carbohydrate diet in adults with type 2 diabetes mellitus in India;Frontiers in Nutrition;2024-08-30

2. A Century of Prolactin: Emerging Perspectives as a Metabolic Regulator;Diabetes/Metabolism Research and Reviews;2024-08-03

3. The risk of coronary artery disease in patients with type 2 diabetes mellitus and metabolic syndrome;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2024-08-02

4. Cardiometabolic effects of hypoprolactinemia;Reviews in Endocrine and Metabolic Disorders;2024-07-30

5. Linkage and association of rs3110045 and rs28499085 variants in the thyrotropin-releasing hormone receptor (TRHR) gene with the risk of familial type 2 diabetes;Aspects of Molecular Medicine;2024-06